EVIDENCE. COMPARISONS. CLEAR NEXT STEPS.FOR US CLINIC TEAMS PROCUREMENT RESEARCH
Expert Q&A

How should the desk turn these interviews into a procurement decision?

Dose Diligence research deskSection 06 · Page 20 of 22Last updated 17 Nov 2026

Require each expert contribution to change an identifiable decision, document or control. Use the following proposed closeout template:

Interview outputWhat to record
Decision ruleWhat facts support proceeding, pausing or rejecting the proposed arrangement?
EvidenceWhich document or primary source supports that rule?
UncertaintyWhat remains unknown or genuinely disputed?
ImplementationWho acts, by when, and what proves completion?
Recheck triggerWhich product, facility, state, price or regulatory change requires reassessment?
Approved quotationExact wording, attribution, interview date and consent to publish

What belongs in the board-ready decision pack?

  • Exact product, presentation, facility, destination and transaction map.
  • Legal and clinical review of the proposed route, including unresolved issues.
  • Facility-specific quality and provenance evidence.
  • State-coverage matrix and operational acceptance tests.
  • Matched cost scenarios separating clinic, patient and payer expenditure.
  • Defined service metrics, exclusions and pilot results.
  • Dependency map and tested fallback process.
  • Reviewed commitments, exit costs, data arrangements and remuneration.
  • Named owners for implementation and ongoing monitoring.

For a time-limited interview, prioritise questions 1–3, 9–12 and 14. Commission separate specialist sessions for clinical transition, quality and privacy rather than asking one expert to certify the whole arrangement.

Explore the table row by row

A working view of the research

Decision rule

What to record
What facts support proceeding, pausing or rejecting the proposed arrangement?

Sources cited on this page

    See the section’s source register for the research context.

    Section sources →